Joel Villanueva Chua

Joel Chua practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Joel Chua's NPI, 1689868382, was assigned on September 5, 2007. Joel Chua holds Maryland license D80290.

Joel Chua's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Joel Chua's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. The medical group on file is University of Maryland Medical Center Gastroenterology and Hepatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Joel Chua practices. Vendor and product names are available with a free account.

Infectious disease is Joel Chua's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Joel Chua's licenses on file in 2 states: Maryland and Delaware.

CMS data shows 472 Medicare services from Joel Chua across 6 procedure codes in 2024, for 124 Medicare patients. Medicare paid $43,667 for them.

CMS counts 124 Medicare patients who saw Joel Chua in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Joel Chua's median patient age at 60, with 41% women.

In 2024, Joel Chua wrote 124 Medicare Part D claims for 30 patients. 89% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $644 in total drug cost. In 2023, CMS named 46 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Joel Chua for performance year 2024, reported as part of a group. Joel Chua accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 35 papers to Joel Chua, published from 2013 to 2025. 2021 was the busiest year, with 6. The most frequent topics are Antiviral Agents, HIV Infections and SARS-CoV-2. Joel Chua has published most often in J Med Virol. Joel Chua's most frequent co-authors are Shivakumar Narayanan, MD, Jennifer S. Husson, MD and Bruce L. Gilliam, MD.

Dmand AI links Joel Chua to 1 clinical trial. Conditions studied include Hepadnaviridae Infections and Hepatitis B.

CMS Open Payments shows 21 general payments to Joel Chua from 5 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 73% of the total. Gilead Sciences, Inc. paid the most, $8,083.